SE431612B - Framstellning av en injicerbar komposition innehallande 5-metyltetrahydrohomofolat eller motsvarande fria syra - Google Patents
Framstellning av en injicerbar komposition innehallande 5-metyltetrahydrohomofolat eller motsvarande fria syraInfo
- Publication number
- SE431612B SE431612B SE7310220A SE7310220A SE431612B SE 431612 B SE431612 B SE 431612B SE 7310220 A SE7310220 A SE 7310220A SE 7310220 A SE7310220 A SE 7310220A SE 431612 B SE431612 B SE 431612B
- Authority
- SE
- Sweden
- Prior art keywords
- methyltetrahydrohomofolate
- preparation
- composition containing
- free acid
- injectable composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00274749A US3856959A (en) | 1972-07-24 | 1972-07-24 | Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE431612B true SE431612B (sv) | 1984-02-20 |
Family
ID=23049461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7310220A SE431612B (sv) | 1972-07-24 | 1973-07-23 | Framstellning av en injicerbar komposition innehallande 5-metyltetrahydrohomofolat eller motsvarande fria syra |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3856959A (sv) |
| JP (1) | JPS5541207B2 (sv) |
| AT (1) | AT329312B (sv) |
| AU (1) | AU476551B2 (sv) |
| BE (1) | BE802709A (sv) |
| CA (1) | CA1006093A (sv) |
| DE (1) | DE2335898A1 (sv) |
| FR (1) | FR2193608B1 (sv) |
| GB (1) | GB1442772A (sv) |
| NL (1) | NL7309977A (sv) |
| SE (1) | SE431612B (sv) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572137A (en) * | 1977-02-22 | 1980-07-23 | Bioresearch Sas Del Dr Livio C | Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts |
| US4927828A (en) * | 1985-03-08 | 1990-05-22 | The Trustees Of Princeton University | Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives |
| US5026851A (en) * | 1985-03-08 | 1991-06-25 | The Trustees Of Princeton University | Pyrido[2,3-]pyrimidine derivatives |
| US4684653A (en) * | 1985-03-08 | 1987-08-04 | The Trustees Of Princeton University | Pyrido(2,3-d)pyrimidine derivatives |
| US4833145A (en) * | 1986-06-30 | 1989-05-23 | The Trustees Of Princeton University | 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives |
| US4902796A (en) * | 1986-10-20 | 1990-02-20 | The Trustees Of Princeton University | 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines |
| US4818819A (en) * | 1986-10-20 | 1989-04-04 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
| US5028608A (en) * | 1989-12-11 | 1991-07-02 | The Trustees Of Princeton University | N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives |
| US9265746B2 (en) * | 2006-05-31 | 2016-02-23 | Merck & Cie | Method for cell-specific targeting |
-
1972
- 1972-07-24 US US00274749A patent/US3856959A/en not_active Expired - Lifetime
-
1973
- 1973-06-27 CA CA175,097A patent/CA1006093A/en not_active Expired
- 1973-07-06 AU AU57820/73A patent/AU476551B2/en not_active Expired
- 1973-07-09 GB GB3252873A patent/GB1442772A/en not_active Expired
- 1973-07-14 DE DE19732335898 patent/DE2335898A1/de not_active Withdrawn
- 1973-07-18 AT AT633073A patent/AT329312B/de not_active IP Right Cessation
- 1973-07-18 NL NL7309977A patent/NL7309977A/xx not_active Application Discontinuation
- 1973-07-23 FR FR7326846A patent/FR2193608B1/fr not_active Expired
- 1973-07-23 SE SE7310220A patent/SE431612B/sv unknown
- 1973-07-24 JP JP8276773A patent/JPS5541207B2/ja not_active Expired
- 1973-07-24 BE BE133796A patent/BE802709A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2335898A1 (de) | 1974-02-07 |
| AT329312B (de) | 1976-05-10 |
| NL7309977A (sv) | 1974-01-28 |
| BE802709A (fr) | 1973-11-16 |
| JPS5541207B2 (sv) | 1980-10-22 |
| FR2193608B1 (sv) | 1976-08-13 |
| AU476551B2 (en) | 1976-09-30 |
| CA1006093A (en) | 1977-03-01 |
| GB1442772A (en) | 1976-07-14 |
| JPS4950113A (sv) | 1974-05-15 |
| US3856959A (en) | 1974-12-24 |
| AU5782073A (en) | 1975-01-09 |
| FR2193608A1 (sv) | 1974-02-22 |
| ATA633073A (de) | 1975-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS1099B6 (is) | Ný samsetning efna (Azapurimones) | |
| SE403966B (sv) | Anordning for forangning eller avdunstning av substanser med hjelp av elektrisk uppvermning | |
| IT942215B (it) | Procedimento per la preparazione di agenti acilanti e composizioni che li contengono | |
| BR6914959D0 (pt) | Preparacao de derivados de acido lisergico e diidrolisergico | |
| SE414497B (sv) | Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider | |
| FI48062C (sv) | Förfarande för framställning av xylitol | |
| SE7811635L (sv) | Forfarande for framstellning av 7 -acylamino-7 -alkoxicefalosporiner eller 6 -acylamino-6 -alkoxipenicilliner | |
| NO140427C (no) | Fremgangsmaate til fremstilling av antibiotikum 1-n-(l-(-)-alfa-hydroksy-gamma-aminobutyryl)-xk-62-2 eller syreaddisjonssalter derav | |
| SE397677B (sv) | Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra | |
| AR192879A1 (es) | Preparacion de compuestos de acido 7-amino-cef-3-em-4-carboxilico | |
| BE766834A (fr) | Composition de matiere colorante | |
| SE431612B (sv) | Framstellning av en injicerbar komposition innehallande 5-metyltetrahydrohomofolat eller motsvarande fria syra | |
| SE416302B (sv) | Forfarande for framstellning av foreningar tillhorande dihydrolysergsyra- och dihydroisolysergsyraserien | |
| SE7510329L (sv) | Framstellning av 5-fluoro-2-metyl-1-(p-metylsultinylbensyliden)-indenyl-3-ettiksyra | |
| CH520130A (de) | Verfahren zur Herstellung von N-Fluordichlormethylthio-sulfamidsäure-Derivaten | |
| SE395897B (sv) | Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror | |
| BE764604A (fr) | Preparation de composes methallylsilicones | |
| SE418746B (sv) | Forfarande for framstellning av 7-aminocefalosporansyra eller 7-aminodesacetoxicefalosporansyra | |
| IT1002168B (it) | Preparazione d acido gliossilico | |
| NO140736C (no) | Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre | |
| NO136538C (no) | Fremgangsm}te for fremstilling av indolderivater | |
| CH545316A (de) | Verfahren zur Herstellung von Acylderivaten | |
| SE382051B (sv) | Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler | |
| DD106186A5 (de) | Herstellung von cephalosporinderivaten | |
| SE394814B (sv) | Forfarande for framstellning av nikotinsyra eller isonikotinsyra |